NO773125L - Fremgangsmaate til fremstilling av 1-amino-2-hydroksy-3-heterocykloksypropan - Google Patents

Fremgangsmaate til fremstilling av 1-amino-2-hydroksy-3-heterocykloksypropan

Info

Publication number
NO773125L
NO773125L NO773125A NO773125A NO773125L NO 773125 L NO773125 L NO 773125L NO 773125 A NO773125 A NO 773125A NO 773125 A NO773125 A NO 773125A NO 773125 L NO773125 L NO 773125L
Authority
NO
Norway
Prior art keywords
group
formula
hydroxy
salts
propanol
Prior art date
Application number
NO773125A
Other languages
English (en)
Norwegian (no)
Inventor
Franz Ostermayer
Herbert Schroeter
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO773125L publication Critical patent/NO773125L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D263/06—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by oxygen atoms, attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO773125A 1976-10-05 1977-09-09 Fremgangsmaate til fremstilling av 1-amino-2-hydroksy-3-heterocykloksypropan NO773125L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1263576A CH607585A5 (en) 1976-10-05 1976-10-05 Process for the preparation of 2-[3'-(2-(3,4-dimethoxy-phenyl)ethylamino)-2'-hydroxypropoxy]-3-cyanop yridine

Publications (1)

Publication Number Publication Date
NO773125L true NO773125L (no) 1978-04-06

Family

ID=4384944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO773125A NO773125L (no) 1976-10-05 1977-09-09 Fremgangsmaate til fremstilling av 1-amino-2-hydroksy-3-heterocykloksypropan

Country Status (21)

Country Link
JP (1) JPS5350177A (fr)
AT (1) AT358037B (fr)
AU (1) AU514676B2 (fr)
BE (1) BE858867A (fr)
CA (1) CA1105021A (fr)
CH (1) CH607585A5 (fr)
DE (1) DE2740678A1 (fr)
DK (1) DK402877A (fr)
ES (1) ES462389A1 (fr)
FI (1) FI772681A7 (fr)
FR (1) FR2367065A1 (fr)
GB (1) GB1591723A (fr)
GR (1) GR71677B (fr)
IE (1) IE45692B1 (fr)
IL (1) IL53013A (fr)
NL (1) NL7710394A (fr)
NO (1) NO773125L (fr)
NZ (1) NZ185267A (fr)
PT (1) PT67048B (fr)
SE (1) SE7710250L (fr)
ZA (1) ZA775698B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210653A (en) * 1978-06-27 1980-07-01 Merck & Co., Inc. Pyridyloxypropanolamines
US4208416A (en) * 1978-06-27 1980-06-17 Merck & Co., Inc. N-Aralkyl containing cyanopyridines
DK267779A (da) * 1978-06-27 1979-12-28 Merck & Co Inc Fr&mgangsmaade til fremstilling af n-aralkylamino-propoxycyanopyridiner
GB8510146D0 (en) * 1985-04-20 1985-05-30 Smith Kline French Lab Chemical compounds & processes
DE3776011D1 (de) * 1986-06-30 1992-02-27 Toyo Jozo Kk 2-substituierte alkoxy-3-substituierte pyrazine.
AU1580001A (en) * 1999-11-15 2001-05-30 Eli Lilly And Company Process for the preparation of aryloxy propanolamines

Also Published As

Publication number Publication date
AU2912577A (en) 1979-04-05
FR2367065A1 (fr) 1978-05-05
JPS5350177A (en) 1978-05-08
ATA648777A (de) 1980-01-15
CA1105021A (fr) 1981-07-14
IL53013A0 (en) 1977-11-30
DK402877A (da) 1978-04-06
NZ185267A (en) 1979-07-11
BE858867A (fr) 1978-03-20
IE45692L (en) 1978-04-05
FI772681A7 (fi) 1978-04-06
AT358037B (de) 1980-08-11
NL7710394A (nl) 1978-04-07
SE7710250L (sv) 1978-04-06
AU514676B2 (en) 1981-02-19
IL53013A (en) 1981-09-13
PT67048B (de) 1979-02-16
ES462389A1 (es) 1978-07-01
IE45692B1 (en) 1982-10-20
GB1591723A (en) 1981-06-24
FR2367065B1 (fr) 1980-10-10
GR71677B (fr) 1983-06-21
ZA775698B (en) 1978-05-30
PT67048A (de) 1977-10-01
DE2740678A1 (de) 1978-04-06
CH607585A5 (en) 1978-09-15

Similar Documents

Publication Publication Date Title
US4310527A (en) Etherified hydroxy quinazolone compounds
EP0148725B1 (fr) Dérivés de sulfonamido-benzamides
US4353900A (en) 9-(Arylalkyl or aroylalkyl)-1-oxa-4,9-diazaspiro(5.5)undecan-3-ones
CA1124241A (fr) Aminoalcools n-alkyles et leurs sels; methodes pour les preparer, et compositions pharmaceutiques contenant ces substances
NO151743B (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme derivater av 3-amino-1,2-propandiol
NO303448B1 (no) 1-acylpiperidinforbindelser, deres anvendelse for fremstilling av legemidler samt legemidler inneholdende dem
AU3642995A (en) Substituted aryl piperazines as neurokinin antagonists
CA1129421A (fr) Procedes d'obtention de 1-aryloxy-3-nitratoalkylamino-2-propanols
NO126734B (fr)
NO770176L (no) Oksygererte n-aryl-diazacykler.
US3674799A (en) (4'-(phenyl-3 6-dihydro-1-(2h)-pyridyl)-2-hydroxy propoxy-anilides and derivatives thereof
EP0775118B1 (fr) Derives de benzimidazole presentant une activite dopaminergique
GB2046259A (en) Amino-alcohol derivatives and pharmaceutical compositions containing them
RU2284997C2 (ru) Производные пиримидина и фармацевтическая композиция
EP0014997A1 (fr) Dérivés de 4-aryloxy- et 4-arylthio-3-phénylpipéridine, procédé pour la préparation de tels composés et compositions pharmaceutiques les contenant
US4363808A (en) N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
US4321254A (en) Antiallergic imidodisulfamides
US4442102A (en) 1,5-Diphenylpyrazolin-3-one compounds, process and intermediates for preparation thereof and pharmaceutical compositions containing same
GB1600969A (en) Heterocyclic compounds
IE45692B1 (en) 1-amino-2-hydroxy-3-heterocyclyloxy-propanes
NO852663L (no) Fremgangsmaate ved fremstilling av 3-aminocarbonylmethoxy-5-fenylpyrazol-forbindelser.
NO782389L (no) Piperidinopropanoler.
CA1243033A (fr) Preparation de 4-¬2-(dialcoylamino)ethyl| isatines
EP0147973A1 (fr) Dérivés des tétrazolecarboxanilides
NO803653L (no) Fremgangsmaate til fremstilling av nye derivater til 2-amino-etanol.